10 employees
Rejuvenate Biomed is a science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.
2017
$18M
from 3 investors over 3 rounds
Rejuvenate Biomed raised $18M on October 12, 2021
Investors: Vesalius Biocapital and Rejuveron Life Sciences AG
Rejuvenate Biomed raised $3.8M on March 2, 2021
Investors: Vesalius Biocapital